Kenn Samala· @KSamalaMD · X·· 1 天前评分70
正文
暂无中文译文，显示英文原文。
Temab-A : a novel anti c-met protein ADC #ESMO26
16 浏览 · 0 赞 · 0 转发 · 1 回复
会议摘要
1017P按 Developmental therapeutics 对上
Phase 1 first-in-human (FIH) results of YL211, a c-Met targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors
https://esmocongress.esmo.orgNCT06110663NCT06110663按 - **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy 对上
- **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
https://esmocongress.esmo.org帖内回复
- Kenn Samala@KSamalaMD
Median PFS was 6.8 mos and median OS was 13.8 in the overall EGFRwt cohort #ESMO26
来源：Kenn Samala · x.com